BMC pharmacology & toxicology

How Surfactants Change Protein Coating on Solid Lipid Nanoparticles, Including Molecular Interaction Insights

Updated

Abstract

Essence

On , surfactant-driven formation changed ceftriaxone release and slightly reduced antibacterial activity.

Evidence

This in vitro nanoparticle study used stearic-acid solid lipid nanoparticles incubated with 5% fetal bovine serum, plus molecular docking, drug-release testing, and antibacterial assays against Staphylococcus aureus and Pseudomonas aeruginosa.

Caveat

The findings come from an in vitro serum-corona and docking model, and the observed effect on cumulative drug release was modest at 6%.

Simplified

Key numbers

6%
Decrease in cumulative drug release
Cumulative drug release from with formation
2 to 3×
Higher protein adsorption on negatively charged
Comparison of protein adsorption on negatively vs. positively charged

Key figures

Fig. 1
Size changes of five solid lipid nanoparticle formulations after 48 hours in 5% fetal bovine serum
Highlights how nanoparticle size changes over time vary by formulation during formation in serum
40360_2025_1017_Fig1_HTML
  • Panel SLN-1
    Size measured over time shows a slight increase from about 195 nm to 200 nm after 48 hours
  • Panel SLN-2
    Size starts near 155 nm, dips slightly, then increases to about 165 nm by 48 hours
  • Panel SLN-3
    Size fluctuates around 210 nm with a small dip and recovery by 48 hours
  • Panel SLN-4
    Size remains relatively stable near 275 nm with a slight upward trend over 48 hours
  • Panel SLN-5
    Size stays around 265–270 nm with minimal change over 48 hours
Fig. 2
Surface charge changes of over 48 hours in serum-containing medium
Highlights how surface charge of nanoparticles becomes more negative over time in serum, affecting formation dynamics
40360_2025_1017_Fig2_HTML
  • Panels SLN-1 to SLN-5
    measured at 0 h, 1 h, 6 h, 24 h, and 48 h for five stearic acid nanoparticle formulations; all formulations show increasingly negative zeta potential over time, with -1 and SLN-2 appearing to reach more negative values than others by 48 h
Fig. 3
Size and surface charge of five solid lipid nanoparticle formulations over 90 days of storage
Highlights size stability and distinct negative surface charges across formulations after prolonged storage at 4 °C
40360_2025_1017_Fig3_HTML
  • Panel A
    Mean sizes of -1 to SLN-5 on day 1 and day 90, with SLN-4 and SLN-5 appearing larger than SLN-1 to SLN-3 at both timepoints
  • Panel B
    Mean of SLN-1 to SLN-5 after 90 days, showing all formulations have negative surface charge with SLN-1 and SLN-2 appearing more negative than others
Fig. 4
spectra of with and without from fetal bovine serum
Highlights protein adsorption on nanoparticles by showing characteristic amide peaks in with serum versus controls.
40360_2025_1017_Fig4_HTML
  • Single panel
    Spectra for SLN (black), (red), and SLN + FBS (blue) show peaks at 1636 cm-1 (), 1530-1642 cm-1 (), and 1400 cm-1 () regions indicating protein presence in SLN + FBS.
Fig. 5
Normalized of over time with incubation
Frames stable nanoparticle spectral properties during formation over 48 hours incubation
40360_2025_1017_Fig5_HTML
  • Panel single
    spectra of solid lipid nanoparticles at 0h, 1h, 6h, 24h, and 48h incubation with 5% FBS show overlapping curves with no visible spectral changes
  • Panel inset
    Zoomed region around 220–240 nm wavelength shows all five timepoint spectra closely overlapping without shifts or intensity changes
1 / 5

Full Text

What this is

  • This research explores the formation of a on () synthesized from stearic acid using dual surfactants.
  • It examines how the affects drug release dynamics and antibacterial efficacy of ceftriaxone-loaded .
  • The findings emphasize the importance of nanoparticle surface charge and surfactant composition in modulating protein interactions and drug delivery.

Essence

  • formation on significantly influences drug release and antibacterial efficacy. Higher negative surface charge correlates with increased protein adsorption, which reduces cumulative drug release by 6%.

Key takeaways

  • Protein adsorption on is influenced by surface charge; formulations with more negative zeta potentials adsorbed higher amounts of protein.
  • The reduced cumulative drug release by 6%, impacting the efficacy of ceftriaxone against bacterial strains.
  • Higher concentrations of SDS in the formulation decreased overall formation, indicating a dual role of surfactants in nanoparticle stabilization and protein interaction.

Caveats

  • The study primarily focuses on in vitro conditions, which may not fully represent in vivo behavior of in biological systems.
  • Further research is needed to characterize the biological roles of proteins in the corona to enhance targeted drug delivery strategies.

Definitions

  • Protein corona: A layer of proteins that adsorb onto the surface of nanoparticles, influencing their behavior in biological environments.
  • Solid lipid nanoparticles (SLNs): Nanoparticles made from solid lipids that serve as carriers for drug delivery, offering advantages like biocompatibility and controlled release.

Simplified

Funding

Competing interests

0 of 2
authors report competing interests
2 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free